Research Articles:

• 01Krishan Kumar, Shiv Govind Rawat, Manjit, Mohini Mishra, Priya, Ajay Kumar, Ruchi Chawla, "Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer." International Journal of Biological Macromolecules (2023): 126057. (Impact Factor 8.2)
• 02Krishan Kumar, Rinki Verma, Manjit, Priya, Mohini Mishra, Varsha Rani, Ruchi Chawla “In vivo cancer microenvironment responsive glycan receptor targeted nanoparticles for gemcitabine delivery to Benzo[a]pyrene induced lung cancer model’’ AAPS PharmSciTech (2023) 25,2. (Impact Factor 3.3)
• 03Varsha Rani, Rinki Verma, Krishan Kumar, Ruchi Chawla, "Role of pro-inflammatory cytokines in Alzheimer's disease and neuroprotective effects of pegylated self-assembled nanoscaffolds." Current Research in Pharmacology and Drug Discovery 4 (2023): 100149. (Impact Factor 3.97)
• 04Rani, Varsha, Rinki Verma, Krishan Kumar, and Ruchi Chawla. "pH-influenced self-assembled stealth nanoscaffolds encapsulating memantine for treatment of Alzheimer’s disease." Journal of Biosciences 48, no. 3 (2023): 31. (Impact Factor 2.9)
• 05Yadav, Akhilesh Kumar, Himanshu Tripathi, Sanjna Rajput, Priya Singh, Ashutosh Kumar Dubey, Krishan Kumar, Ruchi Chawla, and Chandana Rath. "Drug kinetics and antimicrobial properties of quaternary bioactive glasses 81S (81SiO2-(16-x) CaO-2P2O5-1Na2O-xMgO); an in-vitro study." Biomaterials Advances (2023): 213729. (Impact Factor 7.9)
• 06Manjit, Manish Kumar, Krishan Kumar, Madhukiran R Dhondale, Abhishek Jha, Kanchan Bharti, Zinnu Rain, Pradyot Prakash, Brahmeshwar Mishra “Fabrication of dual drug-loaded Polycaprolactone/Gelatin composite nanofibres for full thickness diabetic wound healing” Therapeutic Delivery (2023). (I.F 4.2)
• 07Manjit, Manjit, Manish Kumar, Abhishek Jha, Kanchan Bharti, Krishan Kumar, Punit Tiwari, Ragini Tilak, Virender Singh, Biplob Koch, and Brahmeshwar Mishra. "Formulation and characterization of polyvinyl alcohol/chitosan composite nanofiber co-loaded with silver nanoparticle & luliconazole encapsulated poly lactic-co-glycolic acid nanoparticle for treatment of diabetic foot ulcer." International Journal of Biological Macromolecules (2023): 128978. (Impact Factor 8.2)
• 08Manjit, Manjit, Krishan Kumar, Manish Kumar, Abhishek Jha, Kanchan Bharti, Punit Tiwari, Ragini Tilak, Virendra Singh, Biplob Koch, and Brahmeshwar Mishra. "Fabrication of gelatin coated polycaprolactone nanofiber scaffolds co-loaded with luliconazole and naringenin for treatment of Candida infected diabetic wounds." International Journal of Biological Macromolecules (2024): 129621. (Impact Factor 8.2)
• 09Ruchi Chawla, Venkatanaidu Karri, Varsha Rani, Mohini Mishra, Krishan Kumar "Factorial Design-Based Nanocarrier Mediated Formulation of Efavirenz and Its Characterization." Nano Life 12.02 (2022): 2250002 (Impact Factor 0.8)
• 10Krishan Kumar, Virender Kumar, Jatin Lal, Harmeet Kaur, Jasbir Singh. ‘’ A simple 2D composite image analysis technique for the crystal growth study of L-ascorbic acid’’Microscopy Research and Technique 80.6 (2017): 615-626. (Impact Factor 2.5)
• 11Mohini Mishra, Rinki Verma, Aditya Sharma, Krishan Kumar, Ruchi Chawla, “Evaluation of Gemcitabine and Epigallocatechin-3-gallate loaded solid lipid nanoparticles on benzopyrene induced lung cancer model via intranasal route: Improved pharmacokinetics and safety profile”. AAPS PharmSciTech (Impact Factor 3.3) (Accepted).
• 12Mohini Mishra, Kirti Wasnik, Aditya Sharma, Krishan Kumar, Saurabh Kumar Srivastava Avanish Singh Parmar , Pradip Paik, Ruchi Chawla "QbD-based design of solid lipid nanoparticles of gemcitabine co-loaded with epigallocatechin-3-gallate inhibits proliferation of A549 cells by induction of apoptosis mediated by ROS generation- A prognostic approach in the treatment of lung cancer" Pharmaceutical Research. (Impact Factor 3.8) (Manuscript under review).
• 13Krishan Kumar “Controlled delivery of Doxorubicin by N-acetyl Neuraminic acid decorated Chitosan-PLGA nanoparticles for Lung cancer therapy” (manuscript under preparation).
• 14Krishan Kumar “Development of biodegradable glycosylated PLGA nanoparticles for targeted delivery of gemcitabine to lung cancer cells” (manuscript under preparation).
• 15Krishan Kumar “Design synthesis and biological evaluation of doxorubicin loaded chimeric monoclonal antibody conjugated glycosylated chitosan-Alginate nanoparticles for near infrared fluorescent in vivo imaging of lung cancer” (manuscript under preparation).

Review Articles:

• 01Krishan Kumar, Varsha Rani, Mohini Mishra, Ruchi Chawla ‘’ New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy’’ Current Research in Pharmacology and Drug Discovery 3 (2022): 100103. (Impact Factor 3.97)
• 02Krishan Kumar, Ruchi Chawla. ‘’Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer’’ Journal of Drug Delivery Science and Technology 65 (2021): 102677. (Impact Factor 5)
• 03Sandeep Rathor, Sheikh Aamir, D.C. Bhatt, Krishan Kumar and Vikash Kumar, "A Comprehensive Review on Microbubble Concept, Development and Its Application in Therapeutic Drug Delivery and Clinical Management of Disease." Current Pharmaceutical Biotechnology 22.11 (2021): 1424-1443. (Impact Factor 2.8)
• 04Harmeet Kaur, Virender Kumar, Krishan Kumar, Sandeep Rathor, Parveen Kumari and Jasbir Singh.’’ Polymer Particulates in Drug Delivery’’ Current Pharmaceutical Design, Bentham science 22.19 (2016): 2761-2787. (Impact Factor 3.3)

Oral Presentations:

• 01“Development and Evaluation of Nanoformulation for Targeted Delivery of Gemcitabine for the treatment of Lung Cancer” on 7th June 2024 held at Department of Pharmaceutical Engineering & Technology Indian Institute of Technology, (BHU) Varanasi-221005 (U.P.) India

Conferences/ Seminars/Workshops

• 01Presented a poster titled “Dual Receptor Targeted Nanomedicine for Gemcitabine Delivery in Lung Cancer Treatment” at International Conference on Advanced Materials for Better Tomorrow-II organized by Department of Physics (BHU) & Society for Interdisciplinary Research in Materials & Biology (SIRMB), AMBT 2023 at Banaras Hindu University from 10-13 October 2023.
• 02Presented a poster titled “In vivo cancer microenvironment responsive glycan receptor targeted nanoparticles for gemcitabine delivery to lung cancer model” at 93rd Annual Session of National Academy of Science, India (NASI), organised at BARC, Mumbai from December 03 to 05, 2023.
• 03Participated in Hands-on Training on “Particle size, Shape analysis assisted by AI/ML in Pharmaceutical Formulation and Development” on 29-Sep-2023 at Department of Pharmaceutical Engineering and Technology, IIT (BHU) Varanasi, India.
• 04Participated in for online participation in SERB sponsored SSR Workshop on “Exploring New Avenues and Innovations in Drug Discovery” held on October 27-28th, 2023 at the Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, India
• 05Participated in 18th Annual convection of society of pharmacognosy on “Promotion and Globalization of Indian Herbal Products-perspectives and prospects” at Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India on February 21-22, 2014.
• 06Participated in 2nd National Conference on Breaking New Grounds in Pharmaceutical Research, organised by Department of Pharmacy, Manav Bharti University, Solan, H.P. from 28th-29th March, 2014.

Credentials